Inventor

OTVOS JAMES D

US41 patents

⚠️ This page may combine multiple inventors who share the name “OTVOS JAMES D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

OTVOS JAMES D

LIPOSCIENCE INC

Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results

Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders

Method of determining presence and concentration of lipoprotein X in blood plasma and serum

Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements

Methods for providing personalized lipoprotein-based risk assessments

Multi-parameter diabetes risk evaluations

NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples

CHD risk stratification evaluations for subjects with high levels of large HDL-P

Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same

NMR measurements of NMR biomarker GlycA

Multi-parameter diabetes risk evaluations

Multi-parameter diabetes risk evaluations

NMR quantification of TMAO

NMR analyzers for clinical evaluation of biosamples

Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter

Multi-parameter metabolic vulnerability index evaluations

Multiple-marker risk parameters predictive of conversion to diabetes

Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements

CHD risk stratification evaluations for subjects with high levels of large HDL-P

Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter

Multiple-marker risk parameters predictive of conversion to diabetes

NMR measurements of NMR biomarker GlycA

NMR quantification of TMAO

NMR analyzers for clinical evaluation of biosamples

NMR quantification of TMAO

NMR system and methods for multi-parameter metabolic vulnerability index evaluations

Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter

Multiple-marker risk parameters predictive of conversion to diabetes

Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements

CHD risk stratification evaluations for subjects with high levels of large HDL-P

NMR measurements of NMR biomarker GlycA

Protective HDL particle number evaluations

NMR quantification of TMAO

Multi-parameter diabetes risk evaluations

Methods and systems to detect and quantify the amount of LP-X and other abnormal lipoproteins in a biosample using NMR spectroscopy

Methods and systems for predicting colorectal cancer incidence and mortality

OTVOS JAMES D

Measurement of blood lipoprotein constituents by analysis of data acquired from an NMR spectrometer

Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements

NMR analyzers for clinical evaluation of biosamples

UNIV NORTH CAROLINA STATE

Method and apparatus for measuring classes and subclasses of lipoproteins

JEYARAJAH ELIAS

NMR measurement of clinically relevant ionized biosample constituents such as ionized calcium and/or magnesium